Pulmonary Devices Market Growth | Global Report 2027

report image

Pulmonary Devices Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Type (Therapeutic Devices, Consumables and Accessories, Diagnostic Devices, Monitoring Devices); Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, Others); End User (Hospitals, Homecare Settings, Ambulatory Care Centers), and Geography

Publication Month: Aug 2020 | Report Code: TIPRE00012649 | No. of Pages: 155 | Category: Medical Device | Status: Published

The pulmonary devices market was valued at US$ 18,598.56 million in 2019 and is projected to reach US$ 39,965.01 million by 2027; it is expected to grow at a CAGR of 10.1%from 2020 to 2027.

Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract. The pulmonary devices market growth is mainly attributed to the rising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. Moreover, strategic activities by the manufacturers such as type innovation, type launches, and approvals, as well as R&D investment for advancements in ventilatorsare further expected to foster the market growthduring the forecast period. However, unfavorable reimbursement scenario limitsthe growth of the market.

The impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market in Europe. For instance, Apex Medical is focused towards providing CPAP ventilator solutions as COVID-19 treatment alternative as per the British Medicines and Medical Products Regulatory Agency (MHRA) to the patients with respiratory insufficiency. Additionally, In the United Kingdom (UK), for example, the government has asked automobile manufacturers including Ford, Honda, and Rolls-Royce to temporarily shift part of their assembly line focus from cars to developing respiratory equipment.


Lucrative Regions for Pulmonary Devices Market



Lucrative Regions for Pulmonary Devices Market

Get more information on this report :


Market Insights

Rising Number of COVID-19 Cases Drives Pulmonary Devices Market Growth

Infectious respiratory diseases directly drive demand for respiratory care. COVID-19 is the most recent and significant of these diseases; the pandemic has resulted in a surge in demand for personal protection equipment and ventilators, among others. The demand for ventilators has also grown due to the COVID-19 outbreak, resulting in governmental and industrial support for driving the pace of manufacturing. As of now, the virus has infected more than a quarter of a million people globally. With the continued spread of this virus, which can cause pneumonia and difficulty breathing, hospitals are facing a limited supply of ventilators. For instance, in Italy, hospitals have been overwhelmed with patients in respiratory failure, and medical staffs have to make difficult life-or-death decisions about which patients receive ventilators. As the shortage and prevalence of respiratory diseases increase, the global pulmonary device market is expected to grow at a steady pace.

For now, the impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market. In addition, the threat will have a lasting impact on governments and regulatory agencies in terms of future preparedness when it comes to the next pandemic.Today, governments worldwide are playing catch-up, swiftly intervening in an attempt to create alliances with manufacturers to handle the COVID-19 threat. And, international regulatory agencies are considering accelerated approval of certain respiratory devices.


Type-BasedInsights

Based on type, the pulmonary devices market is segmented into therapeutic devices, consumables and accessories, diagnostic devices, and monitoring devices. The therapeutic devices segment held the largest share of the market in 2019.However, the consumables and accessories segment is anticipated to register the highest CAGR during the forecast period. The therapeutic devices for pulmonary diseases include standalone highly advanced respiratory systems such as positive airway pressure devices, ventilators, oxygen concentrators, to smaller regular patient usage devices such as portable oxygen concentrators, inhalers, nebulizers, humidifiers, oxygen hoods, and pumps.

Pulmonary Devices Market, by Type– 2019and 2027



Pulmonary Devices Market, by Type– 2019and 2027

Get more information on this report :


Application-Based Insights

Based on application, the pulmonary devices marketis segmented into COPD, asthma, sleep apnea, infectious disease and others. The COPD segment held the largest share of the market in 2019. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.Chronic obstructive pulmonary disorder commonly referred to, as COPD is a group of progressive lung disorders that commonly include bronchitis and emphysema. People having COPD usually suffer from both of the diseases. Smoking tobacco is known to be the top cause of COPD. In addition, long-term exposure by individuals to chemical irritants may also lead to COPD. The disease usually takes a long time to develop and establish.


End User-Based Insights

Based on end user, the pulmonary devices marketis segmented into hospitals, home care settings and ambulatory care centers. The hospitals segment held the largest share of the market in 2019; however, home care settings segment is estimated to register the highest CAGR during the forecast period.Hospitals segment is estimated to hold a considerable share as majority of the patients in emerging and developed countries prefer visiting hospitals for any kind of health-related problem. Further, the increasing number of hospitals and adoption of advanced diagnostic platforms offer lucrative opportunities for the growth of the market for the hospital segment.

Strategic Insights

Report Coverage - Pulmonary Devices Market
Report CoverageDetails
Market Size Value inUS$ 18,598.56 Million in 2019
Market Size Value byUS$ 39,965.01 Million by 2027
Growth rateCAGR of 10.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages155
No. of Tables72
No. of Charts & Figures70
Historical data availableYes
Segments coveredType ; Application ; End User , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches, mergersand acquisitions, collaborations, and expansionsarethe commonly adopted strategies by various companies to expand their footprint worldwide and meet the growing demandby expanding theirrespective product portfolios.The players operating in the pulmonary devices marketadopted the product innovationsstrategy to cater to changing customer demand worldwide, which also permits them to maintain their brand name globally.


Pulmonary Devices Market – byType

  • Therapeutic Devices
  • Consumables and Accessories
  • Diagnostic Devices
  • Monitoring Devices


Pulmonary Devices Market – by Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sleep Apnea
  • Asthma
  • Infectious Diseases
  • Others


Pulmonary Devices Market – by End User

  • Hospitals
  • Home Care Settings
  • Ambulatory Care Centers


Pulmonary Devices Market– by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Koninklijke Philips N.V.
  • Caire Inc. (Chart Industries)
  • Inogen Inc.
  • Invacare Corporation
  • O2 Concepts
  • Nidek Medical Types, Inc.
  • Drive DeVilbiss International
  • GCE Group
  • Besco Medical
  • Inova labs Inc. (ResMed)

Frequently Asked Questions

Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.
The factors that are driving growth of the market are rising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. Moreover, Strategic activities by the manufacturerssuch as type innovation, type launches, and approvals, as well as R&D investment for advancements in ventilatorsare offering lucrative opportunities for the growth of the market.
The pulmonary devicesmarket majorly consists of the players such as Koninklijke Philips N.V, Caire Inc. (Chart Industries), Inogen Inc., Invacare Corporation, O2 Concepts, Nidek Medical Types, Inc., Drive DeVilbiss International, GCE Group, Besco Medical, and Inova labs Inc. (ResMed)amongst others.

The List of Companies - Pulmonary Devices Market

  1. Koninklijke Philips N.V.
  2. Caire Inc. (Chart Industries)
  3. Inogen Inc.
  4. Invacare Corporation
  5. O2 Concepts
  6. Nidek Medical Types, Inc.
  7. Drive DeVilbiss International
  8. GCE Group
  9. Besco Medical
  10. Inova labs Inc. (ResMed)
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pulmonary devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pulmonary devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00012649
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount